Abstract
Abstract: As vitamin D (VD) plays an essential role in inflammatory bowel diseases (IBD), this systematic review aimed to update the participation of this vitamin in the prevention or remission of these diseases. This review has included studies in MEDLINE–PubMed, EMBASE, and Cochrane databases. The authors have followed PRISMA (Preferred Reporting Items for a Systematic Review and Meta-analysis) guidelines. According to the inclusion and exclusion criteria, twenty-two randomized clinical trials were selected. In total, 1,209 patients were included in this systematic review: 1034 received only VD and 175 received VD in combination with calcium. The average doses of VD supplementation were from oral 400 IU daily to 10,000 IU per kilogram of body weight. Single injection of 300,000 IU of VD was also used. Several studies have shown the crucial role that VD plays in the therapeutic approach of IBD due to its effects on the immune system. It effectively decreased inflammatory cytokines such as TNF-α and IFN-γ (p<0.05) and provided a reduction in disease activity assessed through different scores such as Crohn’s Disease Activity Index (CDAI) (p<0.05) and Ulcerative Colitis Disease Activity Index (UCDAI) (p<0.05). Unfortunately, the available clinical trials are not standardized for of doses and routes of administration. Existing meta-analyses are biased because they compare studies using different doses or treatments in combination with different drugs or supplements such as calcium. Even though VD has crucial effects on inflammatory processes, there is still a need for standardized studies to establish how the supplementation should be performed and the doses to be administered.
References
1 . A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019;12(2):113–22.
2 . The four epidemiological stages in the global evolution of inflammatory bowel disease. Nature Rev Gastr Hepatol. 2021;18(1):56–66.
3 . Association of vitamin D with inflammatory bowel disease activity in pediatric patients. J Korean Med Sci. 2019;34(32):e204.
4 . The potential role of phytonutrients flavonoids influencing gut microbiota in the prophylaxis and treatment of inflammatory bowel disease. Front Nutr. 2021;8:798038.
5 . Efficacy of vitamin D in treatment of inflammatory bowel disease: A meta-analysis. Medicine (Baltimore). 2018;97(46):e12662.
6 Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation. Mucosal Immunol. 2021;14(3):667–78.
7 . Associations between inflammatory bowel diseases and vitamin D. Crit Rev Food Sci Nutr. 2019;59(8):1347–56.
8 . Histological scores in inflammatory bowel disease. J Digest Diseases. 2021;22(1):9–22.
9 . Histologic diagnosis of inflammatory bowel diseases. Adv Anat Pathol. 2022;29(1):48–61.
10 British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106.
11 . Epidemiological profile and clinical characteristics of inflammatory bowel diseases in a Brazilian referral center. Arq Gastroenterol. 2021;58(4):483–90.
12 Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease. Medicine (Baltimore). 2019;98(15):e15172.
13 . Treatments of inflammatory bowel disease toward personalized medicine. Arch Pharmacal Research. 2021;44(3):293–309.
14 . Medical management of inflammatory bowel disease. Surg Clin North Am. 2019;99(6):1223–35.
15 Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Cur Medl Res Opinion. 2020;36(9):1457–63.
16 . IBD in the elderly: management challenges and therapeutic considerations. Cur Gastroent Reports. 2019;21(11):60.
17 . P076 The role of dual biologic therapy in inflammatory bowel disease. Am J Gastroenterol. 2021;116(Suppl 1):S20.
18 . Accurate and rapid microfluidic ELISA to monitor Infliximab titers in patients with inflammatory bowel diseases. Analyst. 2022.
19 . Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies. Expert Opin Drug Metab Toxicol. 2022;1–9.
20 . Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatol. 2020;18(1):14–23.
21 . Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res. 2020;9.
22 . Vitamin D in inflammatory bowel disease: more than just a supplement. Curr Opin Gastroenterol. 2018;34(4):217–25.
23 . From gut to blood: the travels and travails of vitamin D supplementation. Am J Clin Nutrition. 2021;114(3):831–2.
24 . The role of vitamin D in inflammatory bowel disease: mechanism to management. Nutrients. 2019;11(5).
25 . The vitamin D positive feedback hypothesis of inflammatory bowel diseases. Med Hypotheses. 2019;127:154–8.
26 Pain severity and vitamin D deficiency in IBD patients. Nutrients. 2019;12(1).
27 . Dietary supplementation with vitamin D, fish oil or resveratrol modulates the gut microbiome in inflammatory bowel disease. Int J Mol Sci. 2021;23(1).
28 . Probiotics and vitamin D/vitamin D receptor pathway interaction: potential therapeutic implications in inflammatory bowel disease. Front Pharmacol. 2021;12:747856.
29 Role of vitamins in skin health: a systematic review. Cur Nutr Reports. 2020;9(3):226–35.
30 . Vitamin D and the immune system in menopause: a review. J Menopausal Med. 2021;27(3):109–14.
31 . Association of vitamin D status with COVID-19 and its severity: Vitamin D and COVID-19: a narrative review. Rev Endocr Metab Disord. 2022;1–21.
32 . Vitamin D: an essential nutrient with versatile functions in nearly all organs. Int J Vitam Nutr Res. 2013;83(2):92–100.
33 . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Inter Medicine. 2009;151(4):264–9, w64.
34 The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71.
35 Cochrane handbook for systematic reviews of interventions. John Wiley & Sons. 2019.
36 . Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial. APMIS: acta pathologica, microbiologica, et immunologica. Scandinavica. 2019;127(10):681–7.
37 . The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis. J Crohns Colitis. 2018;12(8):963–72.
38 The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status. Nutrit Journal. 2019;18(1):16.
39 . Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease. Clin Nutrition (Edinburgh, Scotland). 2018;37(4):1375–82.
40 High-dose vitamin D does not prevent postoperative recurrence of Crohn’s disease in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol. 2021;19(8):1573–82.e5.
41 Oral nano vitamin D supplementation reduces disease activity in ulcerative colitis: a double-blind randomized parallel group placebo-controlled trial. J Clin Gastroenterol. 2019;53(10):e409–e15.
42 P-112 Evaluation of vitamin D supplementation in moderate to severe Crohn’s disease patients using anti-TNF: replacement or immunomodulation? Inflam Bowel Diseases. 2017;23(suppl_11):S40–S.
43 . A randomized clinical trial of vitamin D(3) (cholecalciferol) in ulcerative colitis patients with hypovitaminosis D(3). PeerJ. 2017;5:e3654.
44 . Vitamin D decreases beck depression inventory score in patients with mild to moderate ulcerative colitis: a double-blind randomized placebo-controlled trial. J Diet Suppl. 2019;16(5):541–9.
45 . Vitamin D suppresses proangiogenic factors in patients with ulcerative colitis: A randomized double blind placebo controlled clinical trial. Compl Ther Clin Practice. 2020;39:101086.
46 25-Hydroxyvitamin D concentrations in children with Crohn’s disease supplemented with either 2000 or 400 IU daily for 6 months: a randomized controlled study. J Pediatr. 2014;164(4):860–5.
47 Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. Uni Europ Gastroenterol Journal. 2015;3(3):294–302.
48 . High dose vitamin D3 improves clinical activity in Crohn’s disease: 1215. Off J Amer College Gastroenterol ACG. 2011;106.
49 . Impact of high-dose vitamin D3 supplementation in patients with Crohn’s disease in remission: a pilot randomized double-blind controlled study. Dig Dis Sci. 2017;62(2):448–55.
50 Pilot study evaluating efficacy of 2 regimens for hypovitaminosis d repletion in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016;62(2):252–8.
51 . A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients. Saudi J Gastroenterol. 2016;22(4):316–23.
52 . Therapeutic effect of vitamin d supplementation in a pilot study of Crohn’s patients. Clin Trans Gastroenterol. 2013;4(4):e33.
53 Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab. 2012;97(6):2134–42.
54 Decrease in mucosal IL17A, IFNγ and IL10 expressions in active Crohn’s disease patients treated with high-dose vitamin alone or combined with infliximab. Nutrients. 2020;12(12).
55 Seven weeks of high-dose vitamin D treatment reduces the need for infliximab dose-escalation and decreases inflammatory markers in Crohn’s disease during one-year follow-up. Nutrients. 2021;13(4):1083.
56 Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn’s disease. Clin Exp Immunol. 2015;181(1):19–28.
57 Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens. J Clin Endocrinol Metab. 2014;99(9):3408–17.
58 Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients. Inflammopharmacol. 2014;22(2):95–103.
59 Treatment of vitamin D deficiency in Chinese inflammatory bowel disease patients: A prospective, randomized, open-label, pilot study. J Dig Dis. 2018;19(4):215–24.
60 Measuring vitamin D status in chronic inflammatory disorders: how does chronic inflammation affect the reliability of vitamin D metabolites in patients with IBD? J Clin Med. 2020;9(2).
61 . Comparison of geographic distributions of irritable bowel syndrome with inflammatory bowel disease fail to support common evolutionary roots: irritable bowel syndrome and inflammatory bowel diseases are not related by evolution. Med Hypotheses. 2018;110:31–7.
62 . Inflammatory bowel diseases: review of known environmental protective and risk factors involved. Inflamm Bowel Dis. 2017;23(9):1499–509.
63 Beneficial role of fruits, their juices, and freeze-dried powders on inflammatory bowel disease and related dysbiosis. Plants (Basel). 2021;11(1).
64 . Time to revisit disease classification in IBD: is the current classification of IBD good enough for optimal clinical management? Gastroenterol. 2021.
65 . Genetic and environmental considerations for inflammatory bowel disease. Surg Clin North Am. 2019;99(6):1197–207.
66 . Inflammatory bowel disease pathobiology: the role of the interferon signature. Ann Gastroenterol. 2020;33(2):125–33.
67 . Protease-activated receptors – key regulators of inflammatory bowel diseases progression. J Inflamm Res. 2021;14:7487–97.
68 Th17 Cells in inflammatory bowel disease: cytokines, plasticity, and therapies. J Immunol Res. 2021;2021:8816041.
69 Update: innate lymphoid cells in inflammatory bowel disease. Dig Dis Sci. 2022;67(1):56–66.
70 . Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation. Innate Immun. 2017;23(6):497–505.
71 . Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci. 2021;21(3):270–83.
72 . Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis. NPJ Sys Biol Appl. 2021;7(1):19.
73 . Role of diet in inflammatory bowel disease. Ann Nutr Metab. 2016;68 Suppl 1:33–41.
74 . Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross-sectional study. J Hum Nut Diet. 2021;34(2):257–64.
75 . The role of diet in the pathogenesis and management of inflammatory bowel disease: a review. Nutrients. 2021;13(1):135.
76 . Advances in understanding the role of cytokines in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2018;12(9):907–15.
77 . Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis. Infec Immun. 2021;89(9):e00014–21.
78 Human intestinal macrophages are involved in the pathology of both ulcerative colitis and Crohn disease. Inflam Bowel Dis. 2021;27(10):1641–52.
79 Integrative computational approach identifies immune-relevant biomarkers in ulcerative colitis. FEBS Open Bio. 2021.
80 Inflamed ulcerative colitis regions associated with MRGPRX2-mediated mast cell degranulation and cell activation modules. Defining a New Therapeutic Target. Gastroenterology. 2021;160(5):1709–24.
81 . Crohn disease: epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92(7):1088–103.
82 Dysbiotic microbiota interactions in Crohn’s disease. Gut Microbes. 2021;13(1):1949096.
83 Understanding the molecular drivers of disease heterogeneity in Crohn’s disease using multi-omic data integration and network analysis. Inflam Bowel Dis. 2020;27(6):870–86.
84 . Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol. 2014;20(17):4934–47.
85 . Vitamin D in pediatric health and disease. Pediatr Allergy Immunol. 2020;31(Suppl 24):54–7.
86 . Vitamin D: skin, sunshine, and beyond. Clin Dermatol. 2021;39(5):840–6.
87 . The basics of bone physiology, healing, and osteoporosis. Instr Course Lect. 2021;70:527–36.
88 . Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology (Basel). 2019;8(2).
89 Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013;12(10):976–89.
90 . Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021;292:198235.
91 . Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. 2021;5(1):e10405.
92 . Sources of vitamin D for humans. Int J Vitam Nutr Res. 2021.
93 . Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer. Int J Vitam Nutr Res. 2021;91(1–2):124–32.
94 Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020.
95 Low vitamin D status is associated with inflammation in patients with chronic obstructive pulmonary disease. J Immunol. 2021;206(3):515.
96 . Vitamin D deficiency/insufficiency and challenges in developing global vitamin D fortification and supplementation policy in adults. Int J Vitam Nutr Res. 2012;82(4):237–59.
97 Vitamin D attenuates oxidative damage and inflammation in retinal pigment epithelial cells. Antioxidants (Basel). 2019;8(9).
98 . Role of vitamin D-calcium supplementation on metabolic profile and oxidative stress in gestational diabetes mellitus: A randomized controlled trial. J Obst Gynaecol Res. 2021;47(3):1016–22.
99 . Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study. Ann Palliat Med. 2021;10(1):169–83.
100 Protective effects of vitamin D on learning and memory deficit induced by scopolamine in male rats: the roles of brain-derived neurotrophic factor and oxidative stress. Naunyn-Schmiedeberg’s Arch Pharmacol. 2021;394(7):1451–66.
101 . Vitamin D toxicity due to self-prescription: A case report. J Family Med Prim Care. 2022;11(4):1561–3.
102 European Crohn’s and Colitis Organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease. J Crohns Colitis. 2019;13(6):673–85e.
103 The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease. Intest Res. 2019;17(2):210–7.
104 . The role of dietary factors in inflammatory bowel diseases: New perspectives. J Dig Dis. 2019;20(1):11–7.
105 . Diet and nutrition in the management of inflammatory bowel disease. Indian J Gastroenterol. 2021;40(3):253–64.
106 Vitamin D, vitamin D receptor (VDR) gene polymorphisms (ApaI and FokI), and bone mineral density in patients with inflammatory bowel disease. J Clin Dens. 2021;24(2):233–42.
107 . Vitamin D status and cytokine levels in patients with Crohn’s disease. Int J Vitam Nutr Res. 2011;81(4):205–10.
108 Cathelicidin mediates a protective role of vitamin D in ulcerative colitis and human colonic epithelial cells. Inflamm Bowel Dis. 2020.
109 . IBD: Vitamin D and IBD: moving towards clinical trials. Nat Rev Gastroenterol Hepatol. 2016;13(6):322–3.
110 . Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014;5:151.
111 . Vitamin D modulates intestinal microbiota in inflammatory bowel diseases. Int J Mol Sci. 2021;22(1):362.
112 Mucosal vitamin D signaling in inflammatory bowel disease. Autoimmun Rev. 2020;19(11):102672.
113 . The effect of vitamin D on serum asymmetric dimethylarginine in patients with mild to moderate ulcerative colitis. Int J Vitam Nutr Res. 2020;90(1–2):17–22.
114 . Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol. 2019;13(4):345–59.
115 . Vitamin D receptor regulates intestinal proteins involved in cell proliferation, migration and stress response. Lipids Health Dis. 2014;13:51.
116 . The effect of various doses of oral vitamin D3 supplementation on gut microbiota in healthy adults: a randomized, double-blinded. Dose-response study. Anticancer Res. 2020;40(1):551–6.
117 Effect of chronic vitamin D deficiency on the development and severity of DSS-induced colon cancer in Smad3(-/-) mice. Comp Med. 2020;70(2):120–30.
118 . Aligning the paradoxical role of vitamin D in gastrointestinal immunity. Trends Endocrinol Metab. 2019;30(7):459–66.
119 . Relationships between vitamin D, gut microbiome, and systemic autoimmunity. Front Immunol. 2019;10:3141.
120 Influence of severe vitamin d deficiency on the clinical course of inflammatory bowel disease. Dig Dis Sci. 2021;66(2):587–96.
121 . Vitamin D therapy in adults with inflammatory bowel disease: a systematic review and meta-analysis. Inflam Bowel Dis. 2020;26(12):1819–30.
122 . Can vitamin D induce remission in patients with inflammatory bowel disease? Ann Gastroenterol. 2022;35(2):140–9.
